Related Experiment Video
Updated: Jul 5, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes
Antonia Ceccarelli1, Maria A Rocca, Elisabetta Pagani
1Neuroimaging Research Unit, Scientific Institute and University Ospedale San Raffaele, Milan, Italy.
Abstract:
To assess regional grey matter (GM) changes in a large cohort of multiple sclerosis (MS) patients with different clinical phenotypes, using voxel-based morphometry (VBM) and their correlation with the extent of global and regional T2 lesion volumes (LV), we acquired conventional MRI scans from 71 MS patients with different clinical phenotypes (26 with relapsing-remitting [RR] MS, 27 with secondary progressive [SP] MS and 18 with primary progressive [PP] MS), 28 patients with a clinically isolated syndrome (CIS) suggestive of MS, and 21 controls. No GM loss was found in CIS patients. Compared to CIS patients, those with RRMS had a significant GM loss in the right pre and postcentral gyri. Compared to RRMS, SPMS patients had a significant GM loss in several regions of the fronto-parieto-temporo-occipital lobes, the cerebellum and superior and inferior colliculus, bilaterally, and deep GM structures. Compared to PPMS, SPMS patients had a significant GM loss in the postcentral gyrus, the cuneus, the middle occipital gyrus, the thalamus, the cerebellum, and the superior and inferior colliculus. In all MS groups, regional GM loss was strongly/moderately correlated with brain T2 LV. In SPMS and PPMS patients, a correlation was found between cortical regional GM loss and T2 LV of the corresponding or adjacent lobes. In MS patients, GM volume loss follows different patterns of regional distribution according to the clinical phenotype of the disease, is likely secondary to the presence and topography of focal WM inflammatory-demyelinating lesions, and is more evident in the progressive forms of the disease.
Insights
Grey matter loss in multiple sclerosis (MS) varies by clinical phenotype, with progressive forms showing more significant changes. Lesion volume strongly correlates with regional grey matter loss across all MS types.
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
- Grey matter (GM) atrophy is a key feature of MS pathology, contributing to disability.
- Understanding regional GM changes across different MS phenotypes is crucial for prognosis and treatment.
Purpose of the Study:
- To investigate regional grey matter (GM) volume differences in patients with multiple sclerosis (MS) across various clinical phenotypes.
- To correlate these GM changes with T2 lesion volumes (LV) using voxel-based morphometry (VBM).
- To differentiate GM loss patterns between clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), secondary progressive MS (SPMS), and primary progressive MS (PPMS).
Main Methods:
- Conventional MRI scans were acquired from 71 MS patients (26 RRMS, 27 SPMS, 18 PPMS), 28 CIS patients, and 21 controls.
- Voxel-based morphometry (VBM) was employed to assess regional grey matter (GM) changes.
- Correlation analysis was performed between GM volumes and T2 lesion volumes (LV).
Main Results:
- No GM loss was observed in CIS patients compared to controls.
- RRMS patients showed GM loss in the right pre- and postcentral gyri compared to CIS.
- SPMS patients exhibited significant GM loss in widespread brain regions, cerebellum, and deep GM structures compared to RRMS.
- PPMS patients showed GM loss in specific cortical and subcortical areas compared to SPMS.
- Regional GM loss strongly correlated with brain T2 LV in all MS groups, with regional correlations observed in SPMS and PPMS.
Conclusions:
- Grey matter volume loss in MS follows distinct regional patterns based on clinical phenotype.
- GM atrophy is likely secondary to white matter inflammatory-demyelinating lesions.
- Progressive forms of MS (SPMS and PPMS) demonstrate more pronounced and widespread GM loss.
- The extent and location of T2 lesions are significantly associated with regional GM atrophy.
Related Concept Videos
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Imaging Studies VII: Vascular Imaging
Magnetic Resonance Imaging
Multiple Sclerosis l: Introduction

